Fine dust air pollution (PM2.5) as a cause of chronic inflammatory lung diseases?
Michael Roth, Research Group Leader at University Hospital Basel asks if fine dust air pollution (PM2.5) is a cause of chronic inflammatory lung diseases and provides a most engaging response.
Environmental exposures during early life influence adult disease risk
Carolyn R. Klocke and Pamela J. Lein discuss how an individual’s experiences during early life can influence their risk for disease as an adult.
Living with Chronic Obstructive Pulmonary Diseases (COPD)
More can be done at the local, national and EU level to improve COPD diagnosis, support smoking cessation and advance work and living conditions for people living with COPD.
Cardiovascular disease: A leading cause of disability and premature death
Dr Tejas Patel, a world-renowned interventional cardiologist and endovascular therapist, highlights cardiovascular disease, a leading cause of disability and premature death around the world.
Researchers discover new genetic brain disease
Manchester researchers have contributed towards the discovery of a genetic brain disease which can cause paraplegia and epilepsy in sufferers.
The Japanese Society of Nephrology: Research and education to tackle kidney disease
Here we find out how The Japanese Society of Nephrology engages in research developing human resources, providing lifelong education and disseminating knowledge to the public, to tackle kidney disease and promote health.
Idiopathic pulmonary fibrosis: An incurable lung disease
Steve Jones, Chair Action for Pulmonary Fibrosis and Board Member EU-IPFF and Gisli Jenkins from Nottingham University Hospitals, explain idiopathic pulmonary fibrosis (IPF), an incurable lung disease.
Periodontal disease: Structure of Mfa1 fimbriae
Professor Yoshiaki Hasegawa discusses the structure and biogenesis mechanism of Mfa1 fimbriae from the periodontal pathogen Porphyromonas gingivalis.
Chemistry: Enzyme activity assays for disease diagnosis
Contributing scientists share their thoughts around the field of chemistry, focussing on enzyme activity assays for disease diagnosis, novel drug development validation and nanoparticles.
The cardiovascular disease burden from ambient air pollution in Europe
Thomas Münzel MD, Andreas Daiber PhD, Ulrich Pöschl PhD and Jos Lelieveld PhD discuss the link between air pollution and cardiovascular disease in Europe.
Cardiovascular diseases – how to prevent them
Cardiovascular diseases are on the rise, but so is confusion as to how to prevent them. Shaun Ingram, MD of Cardiac Science takes a look at the data, shares his views and strikes a cautious note of optimism.
Vessel growth in health and disease
John Greenwood PhD FRCPath and Stephen E. Moss PhD from UCL Institute of Ophthalmology discuss the vasculature in health and disease, a major focus of their research.
Research on visual impairment diseases by the U.S.
Here, Open Access Government explore how the National Eye Institute in the U.S is supporting vision research that encompasses visual impairment diseases of people of all ages.
Japan: Challenges around global data sharing for orphan diseases
Makoto Suematsu, President of the Japan Agency for Medical Research and Development (AMED) details the challenges around global data sharing for orphan diseases.
A focus on rare disease: Paroxysmal nocturnal haemoglobinuria (PNH)
Maria Piggin, Chair of PNH Support tells us about the rare disease, paroxysmal nocturnal haemoglobinuria (PNH) and in this area, collaborations for change.
Cardiovascular disease: Opportunities and challenges in the digital health era
In this interview, Chair of the ESC Digital Health Committee, Professor Martin Cowie, details the opportunities and challenges in the digital health era when it comes to the field of cardiovascular disease.
Intramembrane proteases in neurodegenerative diseases
Prof Dr Regina Fluhrer, from the University of Augsburg, explains how intramembrane proteases have been implicated in the emergence of neurodegenerative diseases.
